RACHELLE PACKEY: Open Payments
NPI 1740683077 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 21 payments from 6 companies in 2025. Trend: 2023 $74 · 2024 $493 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $137 |
| Janssen Biotech, Inc. | 5 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| VIVUS LLC | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $17 |
Products named: TREMFYA, RINVOQ, ENTYVIO, SKYRIZI, ZENPEP, QSYMIA, REZDIFFRA, LINZESS.
Industry payments across MI — which companies pay providers there.
